Claes Held

Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Arslani, Ketina; Engstrom, Thomas; Maeng, Michael; Kjoller-Hansen, Lars et al.

Ingår i JACC Cardiovascular Imaging, s. 696-706, 2025

• DOI för Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Muller, Matthew A.; Liu, Richard; Shah, Farheen; Hu, Jiyuan et al.

Ingår i Circulation, 2025

• DOI för Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Thrane, Pernille G.; Maeng, Michael; Maehara, Akiko; Bøtker, Hans Erik et al.

Ingår i Circulation, s. 1767-1779, 2025

• DOI för Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

Hag, Emma; Back, Maria; Henriksson, Peter; Wallert, John et al.

Ingår i European Journal of Cardiovascular Nursing, s. 253-263, 2025

• DOI för Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study
• Ladda ner fulltext (pdf) av Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

A randomized controlled trial of beta-blockers effects on cardiac anxiety

Leissner, Philip; Mars, Katarina; Humphries, Sophia; Jernberg, Tomas et al.

Ingår i General Hospital Psychiatry, s. 26-32, 2025

• DOI för A randomized controlled trial of beta-blockers effects on cardiac anxiety
• Ladda ner fulltext (pdf) av A randomized controlled trial of beta-blockers effects on cardiac anxiety

Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Arslani, Ketina; Engstrom, Thomas; Maeng, Michael; Kjoller-Hansen, Lars et al.

Ingår i JACC Cardiovascular Imaging, s. 696-706, 2025

• DOI för Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy

Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Muller, Matthew A.; Liu, Richard; Shah, Farheen; Hu, Jiyuan et al.

Ingår i Circulation, 2025

• DOI för Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Thrane, Pernille G.; Maeng, Michael; Maehara, Akiko; Bøtker, Hans Erik et al.

Ingår i Circulation, s. 1767-1779, 2025

• DOI för Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

Hag, Emma; Back, Maria; Henriksson, Peter; Wallert, John et al.

Ingår i European Journal of Cardiovascular Nursing, s. 253-263, 2025

• DOI för Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study
• Ladda ner fulltext (pdf) av Associations between cardiac rehabilitation structure and processes and dietary habits after myocardial infarction: a nationwide registry study

A randomized controlled trial of beta-blockers effects on cardiac anxiety

Leissner, Philip; Mars, Katarina; Humphries, Sophia; Jernberg, Tomas et al.

Ingår i General Hospital Psychiatry, s. 26-32, 2025

• DOI för A randomized controlled trial of beta-blockers effects on cardiac anxiety
• Ladda ner fulltext (pdf) av A randomized controlled trial of beta-blockers effects on cardiac anxiety

Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy

Wassberg, Charlotte; Batra, Gorav; Hadziosmanovic, Nermin; Hagström, Emil et al.

Ingår i European Journal of Preventive Cardiology, s. 456-465, 2024

• DOI för Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy
• Ladda ner fulltext (pdf) av Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy

Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety

Leissner, Philip; Held, Claes; Humphries, Sophia; Rondung, Elisabet et al.

Ingår i European Journal of Cardiovascular Nursing, s. 720-727, 2024

• DOI för Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety
• Ladda ner fulltext (pdf) av Association of anxiety and recurrent cardiovascular events: investigating different aspects of anxiety

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial

Leissner, Philip; Mars, Katarina; Humphries, Sophia; Karlström, Patric et al.

Ingår i European Heart Journal, s. 789-797, 2024

• DOI för Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
• Ladda ner fulltext (pdf) av Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Spitzer, Ernest; de la Torre Hernandez, Jose M.; Gudmundsdottir, Ingibjörg Jona; McFadden, Eugene et al.

Ingår i REC: Interventional Cardiology, s. 213-223, 2024

• DOI för Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
• Ladda ner fulltext (pdf) av Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Lund, Lars H; James, Stefan; DeVore, Adam D; Anstrom, Kevin J et al.

Ingår i European Journal of Heart Failure, s. 2453-2463, 2024

• DOI för The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design
• Ladda ner fulltext (pdf) av The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial

Erlinge, David; Andersson, Jonas; Fröbert, Ole; Törnerud, Mattias et al.

Ingår i The Lancet, s. 1750-1759, 2024

• DOI för Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial

Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent

Erlinge, David; Andersson, Jonas; Froebert, Ole; Toernerud, Mattias et al.

Ingår i American Heart Journal, s. 1-10, 2024

• DOI för Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
• Ladda ner fulltext (pdf) av Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent

Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Fritz Hansson, Astrid; Modica, Angelo; Renlund, Henrik; Christersson, Christina et al.

Ingår i Open heart, 2024

• DOI för Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study
• Ladda ner fulltext (pdf) av Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis

Bonaca, Marc P.; Bhatt, Deepak L.; Simon, Tabassome; Fox, Kim Michael et al.

Ingår i Journal of the American College of Cardiology, s. 1627-1636, 2024

• DOI för Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis

Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years

Omerovic, Elmir; James, Stefan; Råmundal, Truls; Fröbert, Ole et al.

Ingår i Cardiovascular Revascularization Medicine, s. 43-50, 2024

• DOI för Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years

Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation

Skogseid, Ebba-Louise; Batra, Gorav; Westerbergh, Johan; Held, Claes et al.

Ingår i Open heart, 2024

• DOI för Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation
• Ladda ner fulltext (pdf) av Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Reynolds, Harmony R.; Cyr, Derek D.; Bairey Merz, C. Noel; Shaw, Leslee J. et al.

Ingår i Journal of the American Heart Association, 2024

• DOI för Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial
• Ladda ner fulltext (pdf) av Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials

Hamo, Carine E.; Liu, Richard; Wu, Wenbo; Anthopolos, Rebecca et al.

Ingår i American Journal of Cardiology, s. 118-124, 2024

• DOI för Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function: a prespecified substudy from REDUCE-AMI

Mars, Katarina; Humphries, Sophia; Leissner, Philip; Jonsson, Martin et al.

Ingår i European Heart Journal - Cardiovascular Pharmacotherapy, s. 708-718, 2024

• DOI för Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function: a prespecified substudy from REDUCE-AMI
• Ladda ner fulltext (pdf) av Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function: a prespecified substudy from REDUCE-AMI

FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction

Böhm, Felix; Mogensen, Brynjölfur; Engstrøm, Thomas; Stankovic, Goran et al.

Ingår i New England Journal of Medicine, s. 1481-1492, 2024

• DOI för FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction

Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy

Kjøller-Hansen, Lars; Maehara, Akiko; Kelbæk, Henning; Matsumura, Mitsuaki et al.

Ingår i Circulation. Cardiovascular Interventions, 2024

• DOI för Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Yndigegn, T.; Lindahl, Bertil; Mars, K.; Alfredsson, J. et al.

Ingår i New England Journal of Medicine, s. 1372-1381, 2024

• DOI för Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Spitzer, Ernest; de la Torre Hernandez, Jose M.; Gudmundsdottir, Ingibjorg Jona; McFadden, Eugene et al.

Ingår i REC-INTERVENTIONAL CARDIOLOGY, 2024

• DOI för Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
• Ladda ner fulltext (pdf) av Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study

Humphries, Sophia; Mars, Katarina; Hofmann, Robin; Held, Claes et al.

Ingår i European Heart Journal Open, 2023

• DOI för Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study
• Ladda ner fulltext (pdf) av Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study

Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials

Newman, Jonathan D.; Anthopolos, Rebecca; Ruggles, Kelly V.; Cornwell, Macintosh et al.

Ingår i American Heart Journal, s. 61-73, 2023

• DOI för Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials

Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Sundström, Johan; Lind, Lars; Nowrouzi, Shamim; Hagström, Emil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 1160-1160, 2023

• DOI för Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Davidsson, Pia; Eketjall, Susanna; Eriksson, Niclas; Walentinsson, Anna et al.

Ingår i Cardiovascular Research, s. 1596-1605, 2023

• DOI för Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease

Nguyen, Dan D.; Spertus, John A.; Alexander, Karen P.; Newman, Jonathan D. et al.

Ingår i Journal of the American College of Cardiology, s. 1697-1709, 2023

• DOI för Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes

Ishak, Divan; Aktaa, Suleman; Lindhagen, Lars; Alfredsson, Joakim et al.

Ingår i Heart, s. 1159-1165, 2023

• DOI för Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
• Ladda ner fulltext (pdf) av Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes

Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Olszowka, Maciej; Hagström, Emil; Hadziosmanovic, Nermin; Ljunggren, Mirjam et al.

Ingår i International Journal of Cardiology, 2023

• DOI för Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome
• Ladda ner fulltext (pdf) av Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Siegbahn, Agneta; Eriksson, Niclas; Assarsson, Erika; Lundberg, Martin et al.

Ingår i PLOS ONE, 2023

• DOI för Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
• Ladda ner fulltext (pdf) av Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.

Gyldenkerne, Christine; Maeng, Michael; Kjøller-Hansen, Lars; Maehara, Akiko et al.

Ingår i Circulation, s. 469-481, 2023

• DOI för Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.

Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index

Fritz Hansson, Astrid; Jensevik Eriksson, Karin; Christersson, Christina; Held, Claes et al.

Ingår i Journal of the American Heart Association, 2023

• DOI för Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index
• Ladda ner fulltext (pdf) av Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non-Vitamin K Oral Anticoagulants Across Varying Body Mass Index

The factor structure of the cardiac anxiety questionnaire, and validation in a post-MI population

Leissner, Philip; Held, Claes; Rondung, Elisabet; Olsson, Erik M.G.

Ingår i BMC Medical Research Methodology, 2022

• DOI för The factor structure of the cardiac anxiety questionnaire, and validation in a post-MI population
• Ladda ner fulltext (pdf) av The factor structure of the cardiac anxiety questionnaire, and validation in a post-MI population

Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study

Rondung, Elisabet; Humphries, Sophia; Olsson, Erik M. G.; Sundelin, Runa et al.

Ingår i Internet Interventions, 2022

• DOI för Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study
• Ladda ner fulltext (pdf) av Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study

Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation: A SWEDEHEART study

Christersson, Christina; Held, Claes; Modica, Angelo; Westerbergh, Johan et al.

Ingår i PLOS ONE, 2022

• DOI för Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation: A SWEDEHEART study
• Ladda ner fulltext (pdf) av Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation: A SWEDEHEART study

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Sjölin, Karl; Aulin, Julia; Wallentin, Lars; Eriksson, Niclas et al.

Ingår i Journal of the American Heart Association, 2022

• DOI för Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
• Ladda ner fulltext (pdf) av Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Independence of clinical events committees: A consensus statement from clinical research organizations

Spitzer, Ernest; Fanaroff, Alexander C.; Gibson, C. Michael; Seltzer, Jonathan et al.

Ingår i American Heart Journal, s. 120-129, 2022

• DOI för Independence of clinical events committees: A consensus statement from clinical research organizations

Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes

Batra, Gorav; Lindbäck, Johan; Becker, Richard C.; Harrington, Robert A. et al.

Ingår i Journal of the American College of Cardiology, s. 1735-1747, 2022

• DOI för Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes

Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Al-Khatib, Sana M.; Wojdyla, Daniel M.; Granger, Christopher B.; Wallentin, Lars et al.

Ingår i Circulation, s. 958-960, 2022

• DOI för Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Heerspink, Hiddo J L; Cherney, David; Postmus, Douwe; Stefánsson, Bergur V et al.

Ingår i Kidney International, s. 174-184, 2022

• DOI för A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
• Ladda ner fulltext (pdf) av A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018

Sharma, Abhinav; Mahaffey, Kenneth W; Gibson, C Michael; Hicks, Karen A et al.

Ingår i American Heart Journal, s. 93-104, 2022

• DOI för Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018
• Ladda ner fulltext (pdf) av Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Held, Claes; Hadziosmanovic, Nermin; Aylward, Philip E.; Hagström, Emil et al.

Ingår i Journal of the American Heart Association, 2022

• DOI för Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy
• Ladda ner fulltext (pdf) av Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA

Mark, Daniel B.; Spertus, John A.; Bigelow, Robert; Anderson, Sophia et al.

Ingår i Circulation, s. 1294-1307, 2022

• DOI för Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

Yndigegn, Troels; Lindahl, Bertil; Alfredsson, Joakim; Benatar, Jocelyne et al.

Ingår i European Heart Journal - Cardiovascular Pharmacotherapy, s. 192-197, 2022

• DOI för Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
• Ladda ner fulltext (pdf) av Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial

Olsson, Erik; Norlund, Fredrika; Rondung, Elisabet; Humphries, Sophia et al.

Ingår i Trials, 2022

• DOI för The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial
• Ladda ner fulltext (pdf) av The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Schillemans, Tessa; Tragante, Vinicius; Maitusong, Buamina; Gigante, Bruna et al.

Ingår i Frontiers in Physiology, 2022

• DOI för Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
• Ladda ner fulltext (pdf) av Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease

Batra, Gorav; Modica, Angelo; Renlund, Henrik; Larsson, Anders et al.

Ingår i Open heart, 2022

• DOI för Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease
• Ladda ner fulltext (pdf) av Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease

Editorial commentary: Emotional distress in women after acute myocardial infarction – still a long way to walk

Held, Claes

Ingår i Trends in cardiovascular medicine, s. 348-349, 2022

• DOI för Editorial commentary: Emotional distress in women after acute myocardial infarction – still a long way to walk

Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients.

Liljeroos, Thea; Puthoopparambil, Soorej Jose; Wallert, John; Held, Claes et al.

Ingår i Disability and Rehabilitation, s. 3834-3842, 2022

• DOI för Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients.
• Ladda ner fulltext (pdf) av Self-perceived cognitive status and cognitive challenges associated with cardiac rehabilitation management: experiences of elderly myocardial infarction patients.

Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study

Humphries, Sophia; Wallert, John; Mars, Katarina; Held, Claes et al.

Ingår i European Heart Journal, s. 491-500, 2022

• DOI för Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study
• Ladda ner fulltext (pdf) av Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study

Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry

Mars, Katarina; Wallert, John; Held, Claes; Humphries, Sophia et al.

Ingår i European Heart Journal, s. 372-379, 2021

• DOI för Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry
• Ladda ner fulltext (pdf) av Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry

Risk markers of incident atrial fibrillation in patients with coronary heart disease

Tomasdottir, Maria; Held, Claes; Hadziosmanovic, Nermin; Westerbergh, Johan et al.

Ingår i American Heart Journal, s. 92-101, 2021

• DOI för Risk markers of incident atrial fibrillation in patients with coronary heart disease
• Ladda ner fulltext (pdf) av Risk markers of incident atrial fibrillation in patients with coronary heart disease

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

Erlinge, David; Maehara, Akiko; Ben-Yehuda, Ori; Bötker, Hans Erik et al.

Ingår i The Lancet, s. 985-995, 2021

• DOI för Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Olszowka, Maciej; Held, Claes; Hadziosmanovic, Nermin; Denchev, Stefan et al.

Ingår i Journal of Internal Medicine, s. 392-403, 2021

• DOI för Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome
• Ladda ner fulltext (pdf) av Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Assessing the external validity of the VALIDATE-SWEDEHEART trial

Rylance, Rebecca T.; Wagner, Philippe; Omerovic, Elmir; Held, Claes et al.

Ingår i Clinical Trials, s. 427-435, 2021

• DOI för Assessing the external validity of the VALIDATE-SWEDEHEART trial
• Ladda ner fulltext (pdf) av Assessing the external validity of the VALIDATE-SWEDEHEART trial

Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial

Bosch, Jackie; Lonn, Eva M.; Dagenais, Gilles R.; Gao, Peggy et al.

Ingår i Stroke, s. 2494-2501, 2021

• DOI för Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial

Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up

Humphries, Sophia; Wallert, John; Norlund, Fredrika; Wallin, Emma et al.

Ingår i Journal of Medical Internet Research, 2021

• DOI för Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up
• Ladda ner fulltext (pdf) av Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up

Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction

Ekerstad, Niklas; Javadzadeh, Dariush; Alexander, Karen P; Bergström, Olle et al.

Ingår i European Heart Journal, s. 89-98, 2021

• DOI för Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction
• Ladda ner fulltext (pdf) av Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction

Natriuretic peptides and incident atrial fibrillation

Tomasdottir, Maria; Held, Claes; Wallentin, Lars; Hijazi, Ziad

Ingår i American Heart Journal, s. 1-1, 2021

• DOI för Natriuretic peptides and incident atrial fibrillation

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Schunk, Stefan J.; Kleber, Marcus E.; März, Winfried; Pang, Shichao et al.

Ingår i European Heart Journal, s. 1742-1756, 2021

• DOI för Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial

Böhm, Felix; Mogensen, Brynjölfur; Östlund, Ollie; Engstrom, Thomas et al.

Ingår i American Heart Journal, s. 92-100, 2021

• DOI för The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
• Ladda ner fulltext (pdf) av The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Batra, Gorav; Ghukasyan, Tatevik; Lindbäck, Johan; Held, Claes et al.

Ingår i JAMA cardiology, s. 1440-1445, 2021

• DOI för Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.

Heerspink, Hiddo J L; Sjöström, C David; Jongs, Niels; Chertow, Glenn M et al.

Ingår i European Heart Journal, s. 1216-1227, 2021

• DOI för Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
• Ladda ner fulltext (pdf) av Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.

Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial

Abtan, Jeremie; Bhatt, Deepak L; Held, Claes; Simon, Tabassome et al.

Ingår i Circulation. Cardiovascular Interventions, 2021

• DOI för Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Reynolds, Harmony R.; Shaw, Leslee J.; Min, James K.; Page, Courtney B. et al.

Ingår i Circulation, s. 1024-1038, 2021

• DOI för Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Bosch, Jackie; Lonn, Eva M.; Jung, Hyejung; Zhu, Jun et al.

Ingår i European Heart Journal, s. 2995-3007, 2021

• DOI för Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
• Ladda ner fulltext (pdf) av Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease

McMurray, John J. V.; Wheeler, David C.; Stefánsson, Bergur V.; Jongs, Niels et al.

Ingår i Circulation, s. 438-448, 2021

• DOI för Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin, Lars; Eriksson, Niclas; Olszowka, Maciej; Grammer, Tanja et al.

Ingår i PLoS Medicine, 2021

• DOI för Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
• Ladda ner fulltext (pdf) av Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Organization of intensive cardiac care units in Europe: Results of a multinational survey

Claeys, M. J.; Roubille, F.; Casella, G.; Zukermann, R. et al.

Ingår i European Heart Journal, s. 993-1001, 2020

• DOI för Organization of intensive cardiac care units in Europe: Results of a multinational survey

Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Mahmoodi, Bakhtawar K.; Tragante, Vinicius; Kleber, Marcus E.; Holmes, Michael V. et al.

Ingår i Circulation, s. 546-555, 2020

• DOI för Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Psycho-affective pathology in adults with congenital heart disease: Important progress is being made within a challenging field

Wallert, John; Held, Claes; Madison, Guy; Olsson, Erik

Ingår i European Journal of Preventive Cardiology, s. 378-380, 2020

• DOI för Psycho-affective pathology in adults with congenital heart disease: Important progress is being made within a challenging field

Attending Heart School and long-term outcome after myocardial infarction: A decennial SWEDEHEART registry study

Wallert, John; Olsson, Erik M. G.; Pingel, Ronnie; Norlund, Fredrika et al.

Ingår i European Journal of Preventive Cardiology, s. 145-154, 2020

• DOI för Attending Heart School and long-term outcome after myocardial infarction: A decennial SWEDEHEART registry study

Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Ögmundsdottir Michelsen, Halldora; Sjölin, Ingela; Schlyter, Mona; Hagström, Emil et al.

Ingår i European Journal of Preventive Cardiology, s. 18-27, 2020

• DOI för Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Garcia, David A; Fisher, Deborah A; Mulder, Hillary; Wruck, Lisa et al.

Ingår i American Heart Journal, s. 1-8, 2020

• DOI för Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

Hilvo, Mika; Wallentin, Lars; Ghukasyan, Tatevik; Held, Claes et al.

Ingår i Journal of the American Heart Association, 2020

• DOI för Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
• Ladda ner fulltext (pdf) av Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

White, Harvey D.; Stewart, Ralph A. H.; Dolby, Anthony J.; Stebbins, Amanda et al.

Ingår i American Heart Journal, s. 97-107, 2020

• DOI för In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

Hijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H. et al.

Ingår i JAMA Network Open, 2020

• DOI för Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

Heerspink, Hiddo J L; Stefansson, Bergur V; Chertow, Glenn M; Correa-Rotter, Ricardo et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 274-282, 2020

• DOI för Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

Stone, Gregg W.; Maehara, Akiko; Ali, Ziad A.; Held, Claes et al.

Ingår i Journal of the American College of Cardiology, s. 2289-2301, 2020

• DOI för Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

Dalgaard, Frederik; Mulder, Hillary; Wojdyla, Daniel M.; Lopes, Renato D. et al.

Ingår i Circulation, s. 10-20, 2020

• DOI för Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

Initial Invasive or Conservative Strategy for Stable Coronary Disease

Maron, David J.; Hochman, Judith S.; Reynolds, Harmony R.; Bangalore, Sripal et al.

Ingår i New England Journal of Medicine, s. 1395-1407, 2020

• DOI för Initial Invasive or Conservative Strategy for Stable Coronary Disease

Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia Secondary Analysis of the ISCHEMIA Randomized Clinical Trial

Reynolds, Harmony R.; Shaw, Leslee J.; Min, James K.; Spertus, John A. et al.

Ingår i JAMA cardiology, s. 773-786, 2020

• DOI för Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia Secondary Analysis of the ISCHEMIA Randomized Clinical Trial

Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach

Humphries, Sophia; Rondung, Elisabet; Norlund, Fredrika; Sundin, Örjan et al.

Ingår i Journal of Medical Internet Research, 2020

• DOI för Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach
• Ladda ner fulltext (pdf) av Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Bhatt, Deepak L.; Fox, Kim; Harrington, Robert A.; Leiter, Lawrence A. et al.

Ingår i Clinical Cardiology, s. 498-505, 2019

• DOI för Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
• Ladda ner fulltext (pdf) av Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Krug-Gourley, Sue; Waterworth, Dawn et al.

Ingår i Journal of the American Heart Association, 2019

• DOI för Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease
• Ladda ner fulltext (pdf) av Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Bhatt, Deepak L.; Steg, Philippe Gabriel; Mehta, Shamir R.; Leiter, Lawrence A. et al.

Ingår i The Lancet, s. 1169-1180, 2019

• DOI för Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

When do we need clinical endpoint adjudication in clinical trials?

Held, Claes

Ingår i Upsala Journal of Medical Sciences, s. 42-45, 2019

• DOI för When do we need clinical endpoint adjudication in clinical trials?
• Ladda ner fulltext (pdf) av When do we need clinical endpoint adjudication in clinical trials?

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

Held, Claes; White, Harvey D.; Stewart, Ralph A. H.; Davies, Richard et al.

Ingår i American Heart Journal, s. 65-73, 2019

• DOI för Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial
• Ladda ner fulltext (pdf) av Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Patel, Riyaz S.; Schmidt, Amand F.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Ingår i Circulation, 2019

• DOI för Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data
• Ladda ner fulltext (pdf) av Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Patel, Riyaz S.; Tragante, Vinicius; Schmidt, Amand F.; McCubrey, Raymond O. et al.

Ingår i Circulation, 2019

• DOI för Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium
• Ladda ner fulltext (pdf) av Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Hochman, Judith S.; Held, Claes; Jeffries, Neal

Ingår i JAMA cardiology, s. 273-286, 2019

• DOI för Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

Fanaroff, Alexander C.; Clare, Robert; Pieper, Karen S.; Mahaffey, Kenneth W. et al.

Ingår i Circulation, s. 863-873, 2019

• DOI för Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

Effects of blood pressure and lipid lowering on cognition Results from the HOPE-3 study

Bosch, Jackie; O'Donnell, Martin; Swaminathan, Balakumar; Lonn, Eva Marie et al.

Ingår i Neurology, 2019

• DOI för Effects of blood pressure and lipid lowering on cognition Results from the HOPE-3 study

Persistent emotional distress after a first-time myocardial infarction and its assocation to late cardiovascular and non-cardiovascular mortality

Lissåker, Claudia; Norlund, Fredrika; Wallert, John; Held, Claes et al.

Ingår i European Journal of Preventive Cardiology, s. 1510-1518, 2019

• DOI för Persistent emotional distress after a first-time myocardial infarction and its assocation to late cardiovascular and non-cardiovascular mortality

Should we consider early de-escalation of maintenance dose of antiplatelet therapy post-ACS?

Held, Claes

Ingår i European Heart Journal - Cardiovascular Pharmacotherapy, s. 149-150, 2019

• DOI för Should we consider early de-escalation of maintenance dose of antiplatelet therapy post-ACS?

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Steg, P. Gabriel; Bhatt, Deepak L.; Simon, Tabassome; Fox, Kim et al.

Ingår i New England Journal of Medicine, s. 1309-1320, 2019

• DOI för Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Wallert, John; Mitchell, Adam; Held, Claes; Hagström, Emil et al.

Ingår i International Journal of Cardiology, s. 19-24, 2019

• DOI för Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study
• Ladda ner fulltext (pdf) av Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Authorship: From credit to accountability - Reflections from the Editors' network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Ingår i Archivos de cardiologia de Mexico, s. 93-99, 2019

• DOI för Authorship: From credit to accountability - Reflections from the Editors' network.

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

McMurray, John J V; DeMets, David L; Inzucchi, Silvio E; Køber, Lars et al.

Ingår i European Journal of Heart Failure, s. 665-675, 2019

• DOI för A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

Authorship: from credit to accountability. Reflections from the Editors' Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Ingår i Clinical Research in Cardiology, s. 723-729, 2019

• DOI för Authorship: from credit to accountability. Reflections from the Editors' Network.

Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients

Khunti, Kamlesh; Jung, Hyejung; Dans, Antonio L.; Held, Claes et al.

Ingår i Canadian Journal of Cardiology, s. 644-652, 2019

• DOI för Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

McMurray, J. J. V.; Solomon, S. D.; Inzucchi, S. E.; Kober, L. et al.

Ingår i New England Journal of Medicine, s. 1995-2008, 2019

• DOI för Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

Authorship: from credit to accountability. Reflections from the Editors' Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Ingår i Basic Research in Cardiology, 2019

• DOI för Authorship: from credit to accountability. Reflections from the Editors' Network.

Authorship: From Credit to Accountability Reflections From the Editors´ Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean Jacques; Aschermann, Michael et al.

Ingår i Anatolian journal of cardiology, s. 281-286, 2019

• DOI för Authorship: From Credit to Accountability Reflections From the Editors´ Network.

Authorship: From credit to accountability - Reflections from the Editors' network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Ingår i Archivos de cardiologia de Mexico, s. 105-111, 2019

• DOI för Authorship: From credit to accountability - Reflections from the Editors' network.

Authorship: From credit to accountability. Reflections from the Editors' Network.

Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael et al.

Ingår i Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, s. 519-525, 2019

• DOI för Authorship: From credit to accountability. Reflections from the Editors' Network.

Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial

Wallert, John; Gustafson, Emelie; Held, Claes; Madison, Guy et al.

Ingår i Journal of Medical Internet Research, 2018

• DOI för Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial
• Ladda ner fulltext (pdf) av Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial

Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease

Vinereanu, Dragos; Wang, Alice; Mulder, Hillary; Lopes, Renato D. et al.

Ingår i Heart, s. 1292-1299, 2018

• DOI för Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

Scirica, Benjamin M.; Bansilal, Sameer; Davoudi, Farideh; Armstrong, Paul W. et al.

Ingår i American Heart Journal, s. 54-60, 2018

• DOI för Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

Tricoci, Pierluigi; Neely, Megan; Whitley, Michael J.; Edelstein, Leonard C. et al.

Ingår i Blood Cells, Molecules & Diseases, s. 37-43, 2018

• DOI för Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Szummer, Karolina; Wallentin, Lars C.; Lindhagen, Lars; Alfredsson, Joakim et al.

Ingår i European Heart Journal, s. 3766-3776, 2018

• DOI för Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

Lindholm, Daniel P; James, Stefan K; Gabrysch, Katja; Storey, Robert F et al.

Ingår i JAMA cardiology, s. 1160-1166, 2018

• DOI för Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

Web-Based Cognitive Behavior Therapy for Depression and Anxiety among Patients with a recent Myocardial Infarction: The U-CARE Heart Randomized Trial

Norlund, Fredrika; Wallin, Emma; Olsson, Erik; Wallert, John et al.

Ingår i Journal of the American College of Cardiology, s. 1884-1884, 2018

• DOI för Web-Based Cognitive Behavior Therapy for Depression and Anxiety among Patients with a recent Myocardial Infarction: The U-CARE Heart Randomized Trial

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Hijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H. et al.

Ingår i European Heart Journal, s. 477-485, 2018

• DOI för A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
• Ladda ner fulltext (pdf) av A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Guimarães, Patrícia O; Leonardi, Sergio; Huang, Zhen; Wallentin, Lars et al.

Ingår i American Heart Journal, s. 28-35, 2018

• DOI för Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Hagström, Emil; Norlund, Fredrika; Stebbins, Amanda; Armstrong, P W et al.

Ingår i Journal of Internal Medicine, s. 83-92, 2018

• DOI för Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial

Dagenais, Gilles R.; Jung, Hyejung; Lonn, Eva; Bogaty, Peter M. et al.

Ingår i Journal of the American Heart Association, 2018

• DOI för Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial
• Ladda ner fulltext (pdf) av Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Sharma, Abhinav; Hijazi, Ziad; Andersson, Ulrika; Al-Khatib, Sana M. et al.

Ingår i Circulation, s. 1666-1676, 2018

• DOI för Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial

Response to Letter: 'Sorrow and cardiovascular events'

Hagström, Emil; Held, Claes

Ingår i Journal of Internal Medicine, s. 415-415, 2018

• DOI för Response to Letter: 'Sorrow and cardiovascular events'

Treatment Activity, User Satisfaction, and Experienced Usability of Internet-Based Cognitive Behavioral Therapy for Adults With Depression and Anxiety After a Myocardial Infarction: Mixed-Methods Study

Wallin, Emma; Norlund, Fredrika; Olsson, Erik; Burell, Gunilla et al.

Ingår i Journal of Medical Internet Research, 2018

• DOI för Treatment Activity, User Satisfaction, and Experienced Usability of Internet-Based Cognitive Behavioral Therapy for Adults With Depression and Anxiety After a Myocardial Infarction: Mixed-Methods Study
• Ladda ner fulltext (pdf) av Treatment Activity, User Satisfaction, and Experienced Usability of Internet-Based Cognitive Behavioral Therapy for Adults With Depression and Anxiety After a Myocardial Infarction: Mixed-Methods Study

Internet-based Cognitive Behavior Therapy for Symptoms of Depression and Anxiety among Patients with a Recent Myocardial Infarction: The U-CARE Heart Randomized Trial

Norlund, Fredrika; Wallin, Emma; Olsson, Erik; Wallert, John et al.

Ingår i Journal of Medical Internet Research, 2018

• DOI för Internet-based Cognitive Behavior Therapy for Symptoms of Depression and Anxiety among Patients with a Recent Myocardial Infarction: The U-CARE Heart Randomized Trial
• Ladda ner fulltext (pdf) av Internet-based Cognitive Behavior Therapy for Symptoms of Depression and Anxiety among Patients with a Recent Myocardial Infarction: The U-CARE Heart Randomized Trial

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention

Tricoci, Pierluigi; Newby, L. Kristin; Clare, Robert M.; Leonardi, Sergio et al.

Ingår i JACC, s. 856-864, 2018

• DOI för Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention

Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry

Norlund, Fredrika; Lissåker, Claudia; Wallert, John; Held, Claes et al.

Ingår i European Journal of Preventive Cardiology, s. 910-920, 2018

• DOI för Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry
• Ladda ner fulltext (pdf) av Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

Ungar, Leo; Clare, Robert M.; Rodriguez, Fatima; Kolls, Bradley J. et al.

Ingår i Journal of the American Heart Association, 2018

• DOI för Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial
• Ladda ner fulltext (pdf) av Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

Pol, Tymon; Held, Claes; Westerbergh, Johan; Lindbäck, Johan et al.

Ingår i Journal of the American Heart Association, 2018

• DOI för Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease: results from the SUPRIM-trial

Olsson, Erik; Norlund, Fredrika; Pingel, Ronnie; Burell, Gunilla et al.

Ingår i Upsala Journal of Medical Sciences, Supplement, s. 167-173, 2018

• DOI för The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease: results from the SUPRIM-trial
• Ladda ner fulltext (pdf) av The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease: results from the SUPRIM-trial

Emotional Distress as a Predictor of Statin Non-adherence among Swedish First-Time Myocardial Infarction Patients, 2006–2013

Lissåker, Claudia T.; Wallert, John; Held, Claes; Olsson, Erik

Ingår i Journal of Psychosomatic Research, s. 30-37, 2017

• DOI för Emotional Distress as a Predictor of Statin Non-adherence among Swedish First-Time Myocardial Infarction Patients, 2006–2013
• Ladda ner fulltext (pdf) av Emotional Distress as a Predictor of Statin Non-adherence among Swedish First-Time Myocardial Infarction Patients, 2006–2013

Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial

Guimaraes, P. Oliveira; Granger, C. B.; Chiswell, K.; Stebbins, A. et al.

Ingår i European Heart Journal, s. 188-188, 2017

• DOI för Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

Hess, Connie N.; Clare, Robert M.; Neely, Megan L.; Tricoci, Pierluigi et al.

Ingår i American Heart Journal, s. 194-203, 2017

• DOI för Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

Pagidipati, Neha J.; Hess, Connie N.; Clare, Robert M.; Akerblom, Axel et al.

Ingår i American Heart Journal, s. 53-61, 2017

• DOI för An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

Ducrocq, Gregory; Schulte, Phillip J.; Budaj, Andrzej; Cornel, Jan H. et al.

Ingår i American Heart Journal, s. 91-99, 2017

• DOI för Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Lindholm, Daniel; Lindbäck, Johan; Armstrong, Paul W.; Budaj, Andrzej et al.

Ingår i Journal of the American College of Cardiology, s. 813-826, 2017

• DOI för Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

Bahit, M. Cecilia; Lopes, Renato D.; Wojdyla, Daniel M.; Held, Claes et al.

Ingår i Heart, s. 623-628, 2017

• DOI för Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
• Ladda ner fulltext (pdf) av Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Hagström, Emil; Held, Claes; Stewart, Ralph A H; Aylward, Philip E et al.

Ingår i Clinical Chemistry, s. 325-333, 2017

• DOI för Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

Valgimigli, Marco; Costa, Francesco; Lokhnygina, Yuliya; Clare, Robert M. et al.

Ingår i European Heart Journal, s. 804-810, 2017

• DOI för Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data

Wallert, John; Tomasoni, Mattia; Madison, Guy; Held, Claes

Ingår i BMC Medical Informatics and Decision Making, s. 1-11, 2017

• DOI för Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data
• Ladda ner fulltext (pdf) av Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data

Temporal changes in myocardial infarction incidence rates are associated with periods of perceived psychosocial stress: A SWEDEHEART national registry study

Wallert, John; Held, Claes; Madison, Guy; Olsson, Erik

Ingår i American Heart Journal, s. 12-20, 2017

• DOI för Temporal changes in myocardial infarction incidence rates are associated with periods of perceived psychosocial stress: A SWEDEHEART national registry study
• Ladda ner fulltext (pdf) av Temporal changes in myocardial infarction incidence rates are associated with periods of perceived psychosocial stress: A SWEDEHEART national registry study

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Ingår i International Journal of Cardiology, s. 271-276, 2017

• DOI för Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease

Carrero, Juan-Jesus; Varenhorst, Christoph; Jensevik, Karin; Szummer, Karolina et al.

Ingår i Kidney International, s. 216-226, 2017

• DOI för Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Stewart, Ralph A H; Hagström, Emil; Held, Claes; Wang, Tom Kai Ming et al.

Ingår i Journal of the American Heart Association, 2017

• DOI för Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
• Ladda ner fulltext (pdf) av Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Szummer, Karolina; Wallentin, Lars; Lindhagen, Lars; Alfredsson, Joakim et al.

Ingår i European Heart Journal, s. 3056-3065, 2017

• DOI för Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014
• Ladda ner fulltext (pdf) av Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Held, Claes; White, Harvey D.; Stewart, Ralph A. H.; Budaj, Andrzej et al.

Ingår i Journal of the American Heart Association, 2017

• DOI för Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Vidal-Petiot, Emmanuelle; Stebbins, Amanda; Chiswell, Karen; Ardissino, Diego et al.

Ingår i European Heart Journal, s. 2813-2822, 2017

• DOI för Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Erlinge, D.; Omerovic, E.; Fröbert, O.; Linder, R. et al.

Ingår i New England Journal of Medicine, s. 1132-1142, 2017

• DOI för Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Hadziosmanovic, Nermin; Armstrong, Paul W. et al.

Ingår i Journal of the American College of Cardiology, s. 1689-1700, 2017

• DOI för Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Guimaraes, Patricia Oliveira; Granger, Christopher B.; Stebbins, Amanda; Chiswell, Karen et al.

Ingår i Journal of the American Heart Association, 2017

• DOI för Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
• Ladda ner fulltext (pdf) av Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study

Wallert, John; Lissåker, Claudia; Madison, Guy; Held, Claes et al.

Ingår i European Journal of Preventive Cardiology, s. 639-646, 2017

• DOI för Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study
• Ladda ner fulltext (pdf) av Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study

Psychological mediators related to clinical outcome in cognitive behavioural therapy for coronary heart disease: A sub-analysis from the SUPRIM trial

Norlund, Fredrika; Olsson, Erik MG; Pingel, Ronnie; Held, Claes et al.

Ingår i European Journal of Preventive Cardiology, s. 917-925, 2017

• DOI för Psychological mediators related to clinical outcome in cognitive behavioural therapy for coronary heart disease: A sub-analysis from the SUPRIM trial

Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry study

Wallert, John; Madison, Guy; Held, Claes; Olsson, Erik

Ingår i International Journal of Cardiology, s. 13-17, 2017

• DOI för Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry study
• Ladda ner fulltext (pdf) av Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry study

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

Harskamp, Ralf E.; Clare, Robert M.; Ambrosio, Giuseppe; Held, Claes et al.

Ingår i European Heart Journal, s. 155-163, 2017

• DOI för Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study

Grönqvist, Helena; Olsson, Erik; Johansson, Birgitta; Held, Claes et al.

Ingår i Journal of Medical Internet Research, 2017

• DOI för Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study
• Ladda ner fulltext (pdf) av Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Zewinger, Stephen; Kleber, Marcus E.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 534-543, 2017

• DOI för Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

Lopes, Renato D.; Guimaraes, Patricia O.; Kolls, Bradley J.; Wojdyla, Daniel M. et al.

Ingår i Blood, s. 2980-2987, 2017

• DOI för Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

Clinical Outcomes Associated With The Duration Of Dual Antiplatelet Therapy With Clopidogrel And Aspirin In Chronic Kidney Disease Patients With Acute Coronary Syndrome

Carrero, Juan J.; Varenhorst, Christoph; Jensevik, Karin; Szummer, Karolina et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 1441-1441, 2016

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

Hess, Paul L.; Wojdyla, Daniel M.; Al-Khatib, Sana M.; Lokhnygina, Yuliya et al.

Ingår i JAMA cardiology, s. 73-79, 2016

• DOI för Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

Déry, Jean-Pierre; Mahaffey, Kenneth W; Tricoci, Pierluigi; White, Harvey D et al.

Ingår i Catheterization and cardiovascular interventions, s. 163-173, 2016

• DOI för Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

Batra, Gorav; Svennblad, Bodil; Held, Claes; Jernberg, Tomas et al.

Ingår i Heart, s. 926-933, 2016

• DOI för All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Ingår i European Journal of Preventive Cardiology, s. 839-846, 2016

• DOI för Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis Results From the TRACER Angiographic Substudy

Popma, Christopher J.; Sheng, Shi; Korjian, Serge; Daaboul, Yazan et al.

Ingår i Circulation. Cardiovascular Interventions, 2016

• DOI för Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis Results From the TRACER Angiographic Substudy

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Stewart, Ralph A. H.; Wallentin, Lars; Benatar, Jocelyne; Danchin, Nicolas et al.

Ingår i European Heart Journal, s. 1993-2001, 2016

• DOI för Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
• Ladda ner fulltext (pdf) av Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Prediction Of Major Bleeding In Revascularized Patients With Acute Coronary Syndromes: Development Of A Novel Biomarker-Based Clinical Prediction Model

Lindholm, Daniel; Lindbäck, Johan; James, Stefan; Becker, Richard et al.

Ingår i Journal of the American College of Cardiology, s. 493-493, 2016

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

Vranckx, Pascal; White, Harvey D.; Huang, Zhen; Mahaffey, Kenneth W. et al.

Ingår i Journal of the American College of Cardiology, s. 2135-2144, 2016

• DOI för Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Bui, An H.; Cannon, Christopher P.; Steg, Philippe Gabriel; Storey, Robert F. et al.

Ingår i Circulation, 2016

• DOI för Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Yusuf, Salim; Bosch, Jackie; Dagenais, Gilles; Zhu, Jun et al.

Ingår i New England Journal of Medicine, s. 2021-31, 2016

• DOI för Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Self-Reported General Health And Outcomes In Patients With Stable Coronary Artery Disease: Experiences From The Global Stability Trial

Stewart, Ralph Alan Huston; Hagström, Emil; Held, Claes; Armstrong, Paul et al.

Ingår i Journal of the American College of Cardiology, s. 2113-2113, 2016

Pooled analysis of adverse event collection from 4 acute coronary syndrome trials

Zimerman, Andre; Lopes, Renato D.; Stebbins, Amanda L.; Guimaraes, Patricia O. et al.

Ingår i American Heart Journal, s. 60-67, 2016

• DOI för Pooled analysis of adverse event collection from 4 acute coronary syndrome trials

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

De Caterina, Raffaele; Andersson, Ulrika; Alexander, John H.; Al-Khatib, Sana M. et al.

Ingår i American Heart Journal, s. 175-183, 2016

• DOI för History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
• Ladda ner fulltext (pdf) av History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

Diabetes Mellitus And Cardiovascular Risk In Patients With Chronic Coronary Heart Disease

Sinnaeve, Peter R.; Hagström, Emil; Armstrong, Paul; Budaj, Andrzej et al.

Ingår i Journal of the American College of Cardiology, s. 2162-2162, 2016

Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Wallentin, Lars; Held, Claes; Armstrong, Paul W.; Cannon, Christopher P. et al.

Ingår i Journal of the American Heart Association, 2016

• DOI för Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

The Relationship Between Tooth Loss, Cardiovascular Biomarkers And Outcomes In Patients With Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Ingår i Journal of the American College of Cardiology, s. 1969-1969, 2016

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Åkerblom, Axel; Clare, Robert M.; Lokhnygina, Yuliya; Wallentin, Lars et al.

Ingår i American Heart Journal, s. 1-8, 2016

• DOI för Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Armaganijan, Luciana V.; Alexander, Karen P.; Huang, Zhen; Tricoci, Pierluigi et al.

Ingår i American Heart Journal, s. 176-184, 2016

• DOI för Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial

Durheim, Michael T.; Cyr, Derek D.; Lopes, Renato D.; Thomas, Laine E. et al.

Ingår i International Journal of Cardiology, s. 589-594, 2016

• DOI för Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial

Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART.

Damman, Peter; Jernberg, Tomas; Lindahl, Bertil; de Winter, Robbert J et al.

Ingår i EuroIntervention, s. 1108-1116, 2016

Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.

Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro et al.

Ingår i Canadian Journal of Cardiology, s. 311-318, 2016

• DOI för Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Yusuf, Salim; Lonn, Eva; Pais, Prem; Bosch, Jackie et al.

Ingår i New England Journal of Medicine, s. 2032-2043, 2016

• DOI för Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Lonn, Eva M.; Bosch, Jackie; Lopez-Jaramillo, Patricio; Zhu, Jun et al.

Ingår i New England Journal of Medicine, s. 2009-2020, 2016

• DOI för Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

Hijazi, Ziad; Lindbäck, Johan; Alexander, John H.; Hanna, Michael et al.

Ingår i European Heart Journal, s. 1582-1590, 2016

• DOI för The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Hijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H. et al.

Ingår i The Lancet, s. 2302-2311, 2016

• DOI för The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Kang, Hyun-Jae; Clare, Robert M.; Gao, Runlin; Held, Claes et al.

Ingår i American Heart Journal, s. 899-+, 2015

• DOI för Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial
• Ladda ner fulltext (pdf) av Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Held, Claes; Hylek, Elaine M; Alexander, John H; Hanna, Michael et al.

Ingår i European Heart Journal, s. 1264-1272, 2015

• DOI för Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Tooth Loss Is Independently Associated With Adverse Outcome But Not Myocardial Infarction In Patients With Chronic Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Ingår i Journal of the American College of Cardiology, 2015

Growth Differentiation Factor-15 (GDF-15) For Prognostication Of Outcomes In Stable Coronary Artery Disease: Experiences From The Stability Trial

Wallentin, Lars; Held, Claes; Stewart, Ralph; Budaj, Andrzej et al.

Ingår i Journal of the American College of Cardiology, 2015

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan L et al.

Ingår i European Journal of Preventive Cardiology, s. 771-778, 2015

• DOI för Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study

Andersen, Kasper; Rasmussen, Finn; Held, Claes; Neovius, Martin et al.

Ingår i BMJ-BRITISH MEDICAL JOURNAL, 2015

• DOI för Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study
• Ladda ner fulltext (pdf) av Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study

Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial

Held, Claes; White, H. D.; Stewart, R. A. H.; Davies, R. et al.

Ingår i European Heart Journal, s. 1104-1104, 2015

Effect of ivabradine on heart rate variability in patients with stable coronary artery disease

Stewart, R. A. H.; Armstrong, P. W.; Chiswell, K.; Hagström, Emil et al.

Ingår i European Heart Journal, s. 1088-1088, 2015

Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

Ducrocq, Gregory; Schulte, P J; Becker, R C; Cannon, C P et al.

Ingår i EuroIntervention, s. 737-745, 2015

• DOI för Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

Balancing the risk of ischaemic and bleeding events in ACS

Ducrocq, G.; Schulte, P. J.; Budaj, A.; Cornel, J. H. et al.

Ingår i European Heart Journal, s. 860-861, 2015

External validation of the biomarker-based ABC-stroke risk score for atrial fibrillation

Hijazi, Ziad; Lindbäck, Johan; Östlund, Olof Petter; Siegbahn, Agneta et al.

Ingår i European Heart Journal, s. 710-711, 2015

Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation: insights from the ARISTOTLE trial

Bahit, M. C.; Lopes, R. D.; Wojdyla, D. M.; Held, Claes et al.

Ingår i European Heart Journal, s. 338-339, 2015

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

van Diepen, Sean; Tricoci, Pierluigi; Podder, Mohua; Westerhout, Cynthia M et al.

Ingår i Journal of the American Heart Association, 2015

• DOI för Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery
• Ladda ner fulltext (pdf) av Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)

Cornel, Jan H.; Tricoci, Pierluigi; Lokhnygina, Yuliya; Moliterno, David J. et al.

Ingår i American Journal of Cardiology, s. 1325-1332, 2015

• DOI för Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)

Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy

Wallentin, Lars C.; Lindbäck, Johan; Held, Claes; Granger, C. B. et al.

Ingår i European Heart Journal, s. 1041-1042, 2015

Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial

Norlund, Fredrika; Olsson, Erik M. G.; Burell, Gunilla; Wallin, Emma et al.

Ingår i Trials, 2015

• DOI för Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial
• Ladda ner fulltext (pdf) av Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized controlled trial

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.

Bagai, Akshay; Huang, Zhen; Lokhnygina, Yuliya; Harrington, Robert A et al.

Ingår i Circulation. Cardiovascular Interventions, 2015

• DOI för Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.

EACPR country of the month initiative: Sweden

Kiessling, Anna; Hambraeus, Kristina; Held, Claes; Norhammar, Anna et al.

Ingår i European Heart Journal, s. 951-952, 2015

Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

Varenhorst, Christoph; Alström, Ulrica; Braun, Oscar Ö; Storey, Robert F et al.

Ingår i Heart, s. 1762-1769, 2014

• DOI för Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

Held, Claes; Tricoci, Pierluigi; Huang, Zhen; Van de Werf, Frans et al.

Ingår i European Heart Journal, s. 246-256, 2014

• DOI för Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

Jones, William Schuyler; Tricoci, Pierluigi; Huang, Zhen; Moliterno, David J et al.

Ingår i American Heart Journal, s. 588-596, 2014

• DOI för Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures

Garcia, David; Alexander, John H; Wallentin, Lars; Wojdyla, Daniel M et al.

Ingår i Blood, s. 3692-3698, 2014

• DOI för Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial

Tricoci, Pierluigi; Lokhnygina, Yuliya; Huang, Zhen; Van de Werf, Frans et al.

Ingår i American Heart Journal, s. 869-8770, 2014

• DOI för Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

Hylek, Elaine M.; Held, Claes; Alexander, John H.; Lopes, Renato D. et al.

Ingår i Journal of the American College of Cardiology, s. 2141-2147, 2014

• DOI för Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

Prognostic implications of major bleeding on mortality in ACS patients: An analysis of the PLATO trial

Ducrocq, G.; Schulte, P. J.; Cannon, C. P.; Becker, R. C. et al.

Ingår i European Heart Journal, s. 724-724, 2014

Dose–Response Relationship of Total and Leisure Time Physical Activity to Risk of Heart Failure: a prospective cohort study

Andersen, Kasper; Daniela, Mariosa; Adami, Hans-Olov; Held, Claes et al.

Ingår i Circulation Heart Failure, s. 701-708, 2014

• DOI för Dose–Response Relationship of Total and Leisure Time Physical Activity to Risk of Heart Failure: a prospective cohort study

Chronic kidney disease is associated with worse outcomes in ACS patients: results from the TRACER trial

Mahaffey, K. W.; Pieper, K.; Vranckx, P.; Tricoci, P. et al.

Ingår i European Heart Journal, s. 687-687, 2014

ApoA1 is independently associated with recurrent ischemic events and death in acute coronary syndrome patients

Oskarsson, A.; Varenhorst, Christoph; Hagström, Emil; Wernroth, Mona-Lisa et al.

Ingår i European Heart Journal, s. 482-482, 2014

SWEDEHEART Annual Report 2012

Hambraeus, Kristina; Held, Claes; Johansson, Per; Svennberg, Lars et al.

Ingår i Scandinavian Cardiovascular Journal, s. 1, 2014

• DOI för SWEDEHEART Annual Report 2012

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Storey, Robert F; James, Stefan K; Siegbahn, Agneta; Varenhorst, Christoph et al.

Ingår i Platelets, s. 517-525, 2014

• DOI för Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

A new biomarker based risk score for predicting major bleeding in atrial fibrillation - the ABC (age, biomarkers, current disease) risk score

Hijazi, Ziad; Lindbäck, Johan; Siegbahn, Agneta; Alexander, J. H. et al.

Ingår i European Heart Journal, s. 357-357, 2014

Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

White, Harvey D.; Held, Claes; Stewart, Ralph; Tarka, Elizabeth et al.

Ingår i New England Journal of Medicine, s. 1702-1711, 2014

• DOI för Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome

Varenhorst, Christoph; Jensevik, Karin; Jernberg, Tomas; Sundstrom, Anders et al.

Ingår i European Heart Journal, s. 969-978, 2014

• DOI för Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome

No misrepresentation of vital status follow-up in PLATO : Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: Challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014

Wallentin, Lars; Becker, Richard C.; Cannon, Christopher P.; Held, Claes et al.

Ingår i International Journal of Cardiology, s. 300-302, 2014

• DOI för No misrepresentation of vital status follow-up in PLATO : Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: Challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

Kotsia, Anna; Brilakis, Emmanouil S.; Held, Claes; Cannon, Christopher et al.

Ingår i American Heart Journal, s. 68-75, 2014

• DOI för Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

Halvorsen, Sigrun; Atar, Dan; Yang, Hongqiu; De Caterina, Raffaele et al.

Ingår i European Heart Journal, s. 1864-1872, 2014

• DOI för Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Mahaffey, Kenneth W.; Held, Claes; Wojdyla, Daniel M.; James, Stefan K. et al.

Ingår i Journal of the American College of Cardiology, s. 1493-1499, 2014

• DOI för Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013

Wallentin, Lars; Becker, Richard C.; Cannon, Christopher P.; Held, Claes et al.

Ingår i International Journal of Cardiology, 2014

• DOI för Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013

Response to Letter Regarding Article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation"

Wallentin, Lars; Lopes, Renato D.; Hanna, Michael; Thomas, Laine et al.

Ingår i Circulation, 2014

• DOI för Response to Letter Regarding Article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation"

Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery

Whellan, David J.; Tricoci, Pierluigi; Chen, Edmond; Huang, Zhen et al.

Ingår i Journal of the American College of Cardiology, s. 1048-1057, 2014

• DOI för Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery

Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)

Mahaffey, Kenneth W.; Huang, Zhen; Wallentin, Lars; Storey, Robert F. et al.

Ingår i American Journal of Cardiology, s. 936-944, 2014

• DOI för Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)

Darapladib for preventing ischemic events in stable coronary heart disease

White, Harvey D; Held, Claes; Stewart, Ralph; Tarka, Elizabeth et al.

Ingår i New England Journal of Medicine, s. 1702-1711, 2014

• DOI för Darapladib for preventing ischemic events in stable coronary heart disease

Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?

Johnston, Nina; Bornefalk-Hermansson, Anna; Schenck-Gustafsson, Karin; Held, Claes et al.

Ingår i European Heart Journal, s. 350-358, 2013

• DOI för Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Vedin, Ola; Hagström, Emil; Stewart, Ralph; Brown, Rebekkah et al.

Ingår i European Journal of Preventive Cardiology, s. 678-685, 2013

• DOI för Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan et al.

Ingår i Journal of the American College of Cardiology, 2013

• DOI för Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Physical activity in patients with stable coronary heart disease: an international perspective

Stewart, Ralph; Held, Claes; Brown, Rebekkah; Vedin, Ola et al.

Ingår i European Heart Journal, s. 3286-3293, 2013

• DOI för Physical activity in patients with stable coronary heart disease: an international perspective

The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART)

Harnek, Jan; Nilsson, Johan; Friberg, Orjan; James, Stefan et al.

Ingår i Scandinavian Cardiovascular Journal, s. 1-10, 2013

• DOI för The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART)

Undertreatment of elderly patients > 80-years with acute coronary syndrome despite high risk and similar benefits from evidence-based treatment as at younger age: results from SVEDEHEART

Held, Claes; Johanson, Per; Edberg, Annika; Bergström, Olle et al.

Ingår i Journal of the American College of Cardiology, 2013

• DOI för Undertreatment of elderly patients > 80-years with acute coronary syndrome despite high risk and similar benefits from evidence-based treatment as at younger age: results from SVEDEHEART

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

Leonardi, Sergio; Tricoci, Pierluigi; White, Harvey D; Armstrong, Paul W et al.

Ingår i European Heart Journal, s. 1723-1731, 2013

• DOI för Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

Risk prediction in stable angina pectoris

Kahan, Thomas; Forslund, Lennart; Held, Claes; Björkander, Inge et al.

Ingår i European Journal of Clinical Investigation, s. 141-151, 2013

• DOI för Risk prediction in stable angina pectoris

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

Wallentin, Lars; Lopes, Renato D; Hanna, Michael; Thomas, Laine et al.

Ingår i Circulation, s. 2166-2176, 2013

• DOI för Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

Use of apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE

Lopes, R. D.; Garcia, D. A.; Wojdyla, D.; Dorian, P. et al.

Ingår i European Heart Journal, s. 98-99, 2013

• DOI för Use of apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE

Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial

Held, Claes; Hylek, E. B.; Alexander, J. H.; Hanna, M. et al.

Ingår i European Heart Journal, s. 99-99, 2013

• DOI för Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial

Difference in causes of death between ticagrelor and clopidogrel in the PLATO trial

Varenhorst, Christoph; Alström, Ulrica; Braun, O. O.; Storey, R. F. et al.

Ingår i European Heart Journal, s. 827-827, 2013

• DOI för Difference in causes of death between ticagrelor and clopidogrel in the PLATO trial

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial

Brilakis, Emmanouil S.; Held, Claes; Meier, Bernhard; Cools, Frank et al.

Ingår i American Heart Journal, s. 474-480, 2013

• DOI för Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial

Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study

Andersen, Kasper; Farahmand, Bahman; Ahlbom, Anders; Held, Claes et al.

Ingår i European Heart Journal, s. 3624-3631, 2013

• DOI för Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study

Differential Prognostic Implications of Peak Troponin Level in Acute Coronary Syndrome Treated With and Without Revascularization

Bagai, Akshay; Huang, Zhen; Lokhnygina, Yuliya; Harrington, Robert A. et al.

Ingår i Circulation, 2013

Arterial Access Site and Outcomes in Patients Undergoing Percutaneous Coronary Intervention With and Without Vorapaxar

Dery, Jean-Pierre P.; Mahaffey, Kenneth; Tricoci, Pierluigi; White, Harvey et al.

Ingår i Circulation, 2013

Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER

Jones, Schuyler; Tricoci, Pierluigi; Huang, Zhen; Moliterno, David J. et al.

Ingår i Circulation, 2013

Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Insights From the TRACER Trial

Armaganijan, Luciana; Lopes, Renato; Huang, Zhen; Tricoci, Pierluigi et al.

Ingår i Circulation, 2013

CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial

Tricoci, Pierluigi; Chen, Edmond; Neely, Megan L.; Warner, Amelia et al.

Ingår i Circulation, 2013

Trends in Reperfusion Strategy 1995-2011 in Sweden. Results From the SWEDEHEART Registry

Held, Claes; Johanson, Per; Edberg, Annika; Mattsson, Eva et al.

Ingår i Circulation, 2013

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

Tricoci, Pierluigi; Huang, Zhen; Held, Claes; Moliterno, David J et al.

Ingår i New England Journal of Medicine, s. 20-33, 2012

• DOI för Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

Improving long-term outcomeafter myocardial infarction

James, Stefan; Held, Claes

Ingår i The Lancet, s. 1290-1291, 2012

• DOI för Improving long-term outcomeafter myocardial infarction

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Brilakis, Emmanouil; Held, Claes; Meier, Bernhard; Cools, Frank et al.

Ingår i Journal of the American College of Cardiology, 2012

• DOI för Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Invasive Strategies And Outcomes For Non-ST-segment Elevation Acute Coronary Syndromes: A Twelve-year Experience From SWEDEHEART

Damman, Peter; Held, Claes; James, Stefan; Jeppsson, Anders et al.

Ingår i Journal of the American College of Cardiology, 2012

• DOI för Invasive Strategies And Outcomes For Non-ST-segment Elevation Acute Coronary Syndromes: A Twelve-year Experience From SWEDEHEART

Total and leisure time physical activity and risk of heart failure: a prospective cohort study

Andersen, Kasper; Mariosa, D.; Adami, H. O.; Held, Claes et al.

Ingår i European Heart Journal, s. 1052-1052, 2012

• DOI för Total and leisure time physical activity and risk of heart failure: a prospective cohort study

Female gender associated with less use of reperfusion in ST-elevation myocardial infarction: a study from the RIKS-HIA registry

Johnston, N.; Bornefalk-Hermansson, Anna; Held, Claes; Schenck-Gustafsson, K.

Ingår i European Heart Journal, s. 468-469, 2012

• DOI för Female gender associated with less use of reperfusion in ST-elevation myocardial infarction: a study from the RIKS-HIA registry

Predictors of low physical activity in patients with stable coronary heart disease in the global STABILITY study

Stewart, R. A. H.; Held, Claes; Brown, R.; Vedin, O. et al.

Ingår i European Heart Journal, s. 953-953, 2012

• DOI för Predictors of low physical activity in patients with stable coronary heart disease in the global STABILITY study

Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

Varenhorst, Christoph; Alström, Ulrica; Scirica, Benjamin M.; Hogue, Charles W. et al.

Ingår i Journal of the American College of Cardiology, s. 1623-1630, 2012

• DOI för Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

Hjärt-ultraljud för kliniker

Held, Claes

Ingår i Läkartidningen, 2012

Improving long-term outcome after myocardial infarction

James, Stefan; Held, Claes

Ingår i The Lancet, s. 1290-1291, 2012

• DOI för Improving long-term outcome after myocardial infarction

Gender perspectives on adherence to treatment guidelines in patients with acute myocardial infarction in Sweden

Johnston, Nina; Bornefalk-Hermansson, Anna; Held, Claes; Schenck-Gustafsson, Karin

Ingår i Circulation, 2012

• DOI för Gender perspectives on adherence to treatment guidelines in patients with acute myocardial infarction in Sweden

In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils

Paulsson, J. M.; Moshfegh, A.; Dadfar, E.; Held, Claes et al.

Ingår i Clinical and Experimental Immunology, s. 105-112, 2012

• DOI för In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils

Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study

Held, Claes; Iqbal, Romaina; Lear, Scott A.; Rosengren, Annika et al.

Ingår i European Heart Journal, s. 452-466, 2012

• DOI för Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study

Riks-HIA ska ta fram nytt index för områden med förbättringsutrymme

Jernberg, Tomas; Bergström, Olle; Held, Claes; Johanson, Per et al.

Ingår i Läkartidningen, s. 672-673, 2012

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

Becker, Richard C; Bassand, Jean Pierre; Budaj, Andrzej; Wojdyla, Daniel M et al.

Ingår i European Heart Journal, s. 2933-2944, 2011

• DOI för Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

Long-term effects of an expanded cardiac rehabilitation programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study

Edström Plüss, Cathrine; Billing, Ewa; Held, Claes; Henriksson, Peter et al.

Ingår i Clinical Rehabilitation, s. 79-87, 2011

• DOI för Long-term effects of an expanded cardiac rehabilitation programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study

Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

Jernberg, Tomas; Johanson, Per; Held, Claes; Svennblad, Bodil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 1677-1684, 2011

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Held, Claes; Åsenblad, Nils; Bassand, Jean Pierre; Becker, Richard C. et al.

Ingår i Journal of the American College of Cardiology, s. 672-684, 2011

• DOI för Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study

Bennermo, Marie; Nordin, Margareta; Lundman, Pia; Boqvist, Susanna et al.

Ingår i Journal of Interferon and Cytokine Research, s. 259-264, 2011

• DOI för Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study

Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Mahaffey, Kenneth W.; Wojdyla, Daniel M.; Carroll, Kevin; Becker, Richard C. et al.

Ingår i Circulation, s. 544-554, 2011

• DOI för Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Plasma parathyroid hormone and risk of congestive heart failure in the community

Hagström, Emil; Ingelsson, Erik; Sundström, Johan; Hellman, Per et al.

Ingår i European Journal of Heart Failure, s. 1186-1192, 2010

• DOI för Plasma parathyroid hormone and risk of congestive heart failure in the community

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

White, Harvey; Held, Claes; Stewart, Ralph; Watson, David et al.

Ingår i American Heart Journal, s. 655-66100, 2010

• DOI för Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Hagström, Emil; Hellman, Per; Larsson, Tobias E.; Ingelsson, Erik et al.

Ingår i Circulation, s. 2765-2771, 2009

• DOI för Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Wallentin, Lars; Becker, Richard C.; Budaj, Andrzej; Cannon, Christopher P. et al.

Ingår i New England Journal of Medicine, s. 1045-1057, 2009

• DOI för Ticagrelor versus clopidogrel in patients with acute coronary syndromes

In vivo Extravasated Human Monocytes have an Altered Expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1

Paulsson, J. M.; Held, Claes; Jacobson, S. H.; Lundahl, J.

Ingår i Scandinavian Journal of Immunology, s. 368-376, 2009

• DOI för In vivo Extravasated Human Monocytes have an Altered Expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale

Harrington, Robert A.; Van de Werf, Frans; Armstrong, Paul W.; Aylward, Phil et al.

Ingår i American Heart Journal, s. 327-334, 2009

• DOI för The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale

Evaluation of a web-based ECG-interpretation programme for undergraduate medical students

Nilsson, Mikael; Bolinder, Gunilla; Held, Claes; Johansson, Bo-Lennart et al.

Ingår i BMC Medical Education, s. 25, 2008

• DOI för Evaluation of a web-based ECG-interpretation programme for undergraduate medical students

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease: results of the renal Hope-2 study

Mann, Johannes F. E.; Sheridan, Patrick; McQueen, Matthew J.; Held, Claes et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 645-653, 2008

• DOI för Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease: results of the renal Hope-2 study

Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)

Held, Claes; Sumner, Glen; Sheridan, Patrick; McQueen, Mathew et al.

Ingår i Vascular Medicine, s. 245-253, 2008

• DOI för Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)

In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b

Paulsson, J. M.; Dadfar, E.; Held, Claes; Jacobson, S. H. et al.

Ingår i Clinical and Experimental Immunology, s. 196-204, 2008

• DOI för In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b

Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris

Bjorkander, Inge; Forslund, Lennart; Kahan, Thomas; Ericson, Mats et al.

Ingår i Cardiology, s. 126-133, 2008

• DOI för Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris

Effects of Expanded Cardiac Rehabilitation on Psychosocial Status in Coronary Artery Disease with Focus on Type D Characteristics

Karlsson, Monica Rydell; Edström-Plüss, Catrin; Held, Claes; Henriksson, Peter et al.

Ingår i Journal of behavioral medicine, s. 253-261, 2007

• DOI för Effects of Expanded Cardiac Rehabilitation on Psychosocial Status in Coronary Artery Disease with Focus on Type D Characteristics

Venous thromboembolism in association with features of the metabolic syndrome

Ray, J. G.; Lonn, E.; Yi, Q.; Rathe, A. et al.

Ingår i QJM Monthly Journal of the Association of Physicians, s. 679-684, 2007

• DOI för Venous thromboembolism in association with features of the metabolic syndrome

Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery

Held, Claes; Tornvall, Per; Stenestrand, Ulf

Ingår i European Heart Journal, s. 316-325, 2007

• DOI för Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Held, C; Gerstein, H C; Yusuf, S; Zhao, F et al.

Ingår i Circulation, s. 1371-1375, 2007

• DOI för Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease

Paulsson, Josefin; Dadfar, Elham; Held, Claes; Jacobson, Stefan H et al.

Ingår i Atherosclerosis, s. 328-334, 2007

• DOI för Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease

A high-fat meal is accompanied by increased plasma interleukin-6 concentrations

Lundman, Pia; Boquist, Susanna; Samnegård, Ann; Bennermo, Marie et al.

Ingår i NMCD. Nutrition Metabolism and Cardiovascular Diseases, s. 195-202, 2007

• DOI för A high-fat meal is accompanied by increased plasma interleukin-6 concentrations

Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study

Mörtsell, David; Malmqvist, K; Held, Claes; Kahan, T

Ingår i Journal of Internal Medicine, s. 472-479, 2007

• DOI för Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study

Regression of left ventricular hypertrophy in human hypertension with irbesartan

Malmqvist, Karin; Kahan, Thomas; Edner, Magnus; Held, Claes et al.

Ingår i Journal of Hypertension, s. 1167-1176, 2001

Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Spitzer, Ernest; de la Torre Hernández, José M.; Gudmundsdóttir, Ingibjörg Jóna; McFadden, Eugene et al.

Ingår i REC: Interventional Cardiology, s. 213-223, 2024

• DOI för Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
• Ladda ner fulltext (pdf) av Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory

Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials A Guidance Document

Spitzer, Ernest; McFadden, Eugene; Vranckx, Pascal; Garcia-Garcia, Hector M. et al.

Ingår i JACC, s. 805-819, 2019

• DOI för Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials A Guidance Document

Lessons from platelet inhibition and patient outcomes

Held, Claes

Ingår i Current Opinion in Cardiology, s. 355-360, 2012

• DOI för Lessons from platelet inhibition and patient outcomes

Myocardial infarction and artificial time-­constraint: a theoretical framework and national registry study of yearly, monthly, and weekly incidence variation

Wallert, John; Held, Claes; Madison, Guy; Olsson, Erik

s. 788, 2016

Decreased prevalence of psychological distress after acute myocardial infarction from 2006 to 2013

Norlund, Fredrika; Pingel, Ronnie; Held, Claes; Olsson, Erik

2016

Emotional Distress is a Predictor of Poor Long-Term Statin Adherence at Two Years After a Myocardial Infarction

Lissåker, Claudia; Wallert, John; Held, Claes; Olsson, Erik

2016

Myocardial Infarction and Google Searches on "Stress"

Olsson, Erik; Held, Claes; Madison, Guy; Wallert, John

2016

Does a clinical history of gout influence the relationship of serum uric acid levels and cardiovascular outcomes among patients with acute coronary syndromes?

Pagidipati, N.; Hess, C. N.; Clare, R. M.; Åkerblom, Axel et al.

s. 458-458, 2016

Cognitive Ability, Lifestyle Risk Factors, and Two-Year Mortality in First Myocardial Infarction Men: A Swedish National Registry Study

Wallert, John; Madison, Guy; Held, Claes; Olsson, Erik

2016

The Development and Feasablity of an Internet-Based Cognitive Behavioral Intervention to reduce Depression and/or Anxiety after a Myocardial Infarction - The U-CARE Heart study

Norlund, Fredrika; Olsson, Erik; Wallin, Emma; Burell, Gunilla et al.

2016

• DOI för The Development and Feasablity of an Internet-Based Cognitive Behavioral Intervention to reduce Depression and/or Anxiety after a Myocardial Infarction - The U-CARE Heart study

Living alone and depressive symptoms are associated with major cardiovascular events in patients with chronic coronary heart disease

Hagström, Emil; Norlund, Fredrika; Harrington, R. A.; Lopez-Sendon, J. et al.

s. 1144-1144, 2015

U-CARE Heart: A Randomized Controlled Study of the Effects of Internet-based Cognitive Behavior Therapy on Depression and Anxiety in Patients with a Previous Myocardial Infarction: A Clinical Trial Protocol

Grönqvist, Helena; Olsson, Erik; Norlund, Fredrika; Wallin, Emma et al.

2013

U-CARE – internet-based psychosocial care and psychological treatment in connection to somatic disease

Olsson, Erik; Alfonsson, Sven; Ander, Malin; Brantnell, Anders et al.

2013

U-CARE: a research program on psychosocial care via the internet

Olsson, Erik; Alfonsson, Sven; Ander, Malin; Burell, Gunilla et al.

2012

Derivation and validation of STOPSMOKE: An instrument built from Swedish population data for predicting smoking abstinence post myocardial infarction

Wallert, John; Pingel, Ronnie; Schön, Thomas B.; Olsson, Erik et al.

Exercise capacity and muscle strength and risk of vascular disease and arrhythmias: A cohort study of 1.26 million young men

Andersen, Kasper; Held, Claes; Neovius, Martin; Tynelius, Per et al.

Randomized controlled trial of internet-based cognitive behavioral therapy in myocardial infarction with non-obstructive coronary arteries or takotsubo syndrome

Leissner, Philip; Sundelin, Runa; Rondung, Elisabet; Humphries, Sophia et al.